More adverse events occurred in the augmented treatment group than in the standard group ( asparaginase-related hypersensitivity in @ -LSB- @ % -RSB- in the augmented group vs two -LSB- @ % -RSB- in the standard group and asparaginase-related pancreatitis in eight -LSB- @ % -RSB- vs one -LSB- @ % -RSB- ; intravenous methotrexate-related mucositis in @ -LSB- @ % -RSB- vs three -LSB- @ % -RSB- and methotrexate-related stomatitis in @ -LSB- @ % -RSB- vs @ -LSB- @ % -RSB- ) .